9/19/2025

Baxter International has considerably underperformed the Dow over the past year, and analysts are cautious about the stock’s prospects.

Source: Yahoo

9/18/2025

BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.

Source: Yahoo

9/17/2025

The device enables care teams to obtain patient vitals in under one minute and automatically sends data to electronic medical record.

Source: Yahoo

9/16/2025

DEERFIELD, Ill., September 16, 2025--Baxter International Inc. (NYSE:BAX), a leading global medtech company, today launched the Welch Allyn Connex 360 Vital Signs Monitor, its next generation patient monitoring device. As the latest innovation in Baxter’s connected monitoring portfolio, Connex 360 offers an advanced connectivity and security platform, customizable configurations based on a hospital’s clinical routines, and upgrade capabilities that set the stage for future functionality and enha

Source: Yahoo

9/15/2025

The market offers opportunities through increasing adoption due to rising chronic diseases, telehealth integration, and technological advancements. However, reimbursement challenges persist. North America leads due to favorable policies and demographics. Competitive growth is driven by innovation and market expansion.Dublin, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The "Home Infusion Therapy Market by Product Type, Application, Service Model - Global Market Size, Segmental Analysis, Regional Overview,

Source: Yahoo

8/30/2025

On August 18, 2025, Baxter International unveiled its new Hemopatch sealing hemostat, a room-temperature collagen pad tailored for use in both open and minimally invasive surgeries, following a decade-long collaboration with medical experts. This product's development was driven by direct surgeon feedback, highlighting Baxter's approach of addressing specific, real-world clinical needs through practical innovation. We'll explore how delivering a new surgeon-informed hemostatic device could...

Source: Yahoo

8/29/2025

Baxter International Inc. (NYSE:BAX) is one of the most undervalued and overlooked large-cap stocks. On August 4, a Barclays analyst lowered his price target on Baxter International Inc. (NYSE:BAX) to $36 from $41, while maintaining an Overweight rating. The cut followed a sharp 24% decline in the stock after Q2 results, driven by the pause of […]

Source: Yahoo

8/29/2025

Discover why Avanos Medical, Inc. offers a compelling turnaround investment. Click for more on AVNS stock and why I think it is a bargain.

Source: SeekingAlpha

8/26/2025

SAN DIEGO, August 26, 2025--As part of its mission to drive innovation in Medical Affairs automation, BP Logix is pleased to announce the appointment of Dr. Kirk Shepard to the company's Life Sciences Strategic Advisory Board.

Source: Yahoo

8/22/2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospe

Source: Yahoo

8/22/2025

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers.

Source: Yahoo

8/21/2025

Meenal Sethna will replace Michael Shapiro as the infusion therapy provider’s chief financial executive in October.

Source: Yahoo

8/17/2025

For the second quarter, Macquarie Value Fund Institutional Class shares trailed its benchmark, the Russell 1000® Value Index. Read more here.

Source: SeekingAlpha

8/15/2025

NYSE:BAX 1 Year Share Price vs Fair Value Explore Baxter International's Fair Values from the Community and select...

Source: Yahoo

8/13/2025

Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large-cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor letter. The full letter is available for download here. For the second quarter of 2025, the fund reported a net return of 7.24%, outperforming its benchmark, the Russell 1000 […]

Source: Yahoo

8/13/2025

Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% year on year to $2.81 billion. On the other hand, next quarter’s revenue guidance of $2.87 billion was less impressive, coming in 1% below analysts’ estimates. Its non-GAAP profit of $0.54 per share was 11.4% below analysts’ consensus estimates.

Source: Yahoo

8/13/2025

Baxter’s second quarter results were met with a significant negative market reaction following a combination of in-line sales and a notable shortfall in non-GAAP profit. Management attributed the mixed performance primarily to persistent hospital fluid conservation, modest demand in the Medical Products & Therapies and Pharmaceutical segments, and challenges related to product mix. COO Heather Knight highlighted the ongoing effects of lower U.S. patient admissions and evolving hospital protocols

Source: Yahoo

8/12/2025

The Global Multiple Myeloma Market is projected to grow from USD 21.78 billion in 2024 to USD 40.41 billion by 2033, at a CAGR of 7.11%. Growth drivers include rising multiple myeloma cases, advances in targeted therapies like monoclonal antibodies, and the increasing adoption of immunotherapies. Enhanced diagnostics and greater healthcare accessibility are boosting market expansion. Key regions such as the U.S., Europe, and Asia-Pacific, are witnessing heightened therapy adoption. Challenges in

Source: Yahoo

8/12/2025

The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure

Source: Yahoo

8/11/2025

Around 86% of US healthcare providers reported IV fluid shortages following damage to Baxter’s North Carolina facility by Hurricane Helene in September 2024.

Source: Yahoo